Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Oncolytics Biotech, Inc. (NASDAQ: ONCY)

 
ONCY Technical Analysis
5
As on 4th Nov 2015 ONCY Share Price closed @ 0.33 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.60 & Strong Sell for SHORT-TERM with Stoploss of 0.49 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

ONCY Share Price

Open 0.36 Change Price %
High 0.36 1 Day -0.02 -5.71
Low 0.31 1 Week 0.00 0.00
Close 0.33 1 Month 0.00 0.00
Volume 802355 1 Year 0.00 0.00
52 Week High 5.79 | 52 Week Low 2.98
 
NASDAQ USA Most Active Stocks
YHOO 52.58 0.00%
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
MU 44.31 6.39%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
GTAT 0.44 0.00%
SUSQ 14.20 -0.77%
INTC 45.49 2.52%
 
NASDAQ USA Top Gainers Stocks
LOCM 0.09 50.00%
SCHS 0.04 33.33%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
HLIT 3.70 25.42%
OTT 2.39 25.13%
QNST 8.90 20.76%
VRTA 4.00 19.40%
SNSS 2.56 19.07%
GCFB 0.44 18.92%
 
NASDAQ USA Top Losers Stocks
TXCC 0.01 -95.00%
GMETP 0.15 -76.92%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
DVOX 0.05 -44.44%
PRXI 0.21 -43.24%
TRGT 0.96 -41.46%
 
 
ONCY
Daily Charts		 ONCY
Intraday Charts		 Whats New @
Bazaartrend		 ONCY
Free Analysis
 
ONCY Important Levels Intraday
SUPPORT0.00
SUPPORT0.00
RESISTANCE0.38
RESISTANCE0.36
SUPPORT0.30
SUPPORT0.28
SUPPORT0.00
SUPPORT0.00
 
ONCY Target for Month January
Share
4th UP TARGET0
3rd UP TARGET0
2nd UP TARGET0
1st UP TARGET0
1st DOWN TARGET0
2nd DOWN TARGET0
3rd DOWN TARGET0
4th DOWN TARGET0
 
ONCY Weekly Target
4th UP TARGET0.00
3rd UP TARGET0.00
2nd UP TARGET0.00
1st UP TARGET0.00
1st DOWN TARGET0.00
2nd DOWN TARGET0.00
3rd DOWN TARGET0.00
4th DOWN TARGET0.00
 
ONCY Target for Year 2021
4th UP TARGET0
3rd UP TARGET0
2nd UP TARGET0
1st UP TARGET0
1st DOWN TARGET0
2nd DOWN TARGET0
3rd DOWN TARGET0
4th DOWN TARGET0
 
Oncolytics Biotech, Inc. ( NASDAQ USA Symbol : ONCY )
Sector : N/AIndustry:N/AFull Time Employees:N/ABusiness Summary Oncolytics Biotech Inc., a development stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancers. The company develops REOL And Other Stocks in Same Sector
ONCY
0.33 -0.02 (-5.71 %)
LT : Strong Sell
ST : Strong Sell
 
ONCY Other Details
Segment EQ
Market Capital 153322176.00
Sector N/AIndustry:N/AFull Time Employees:N/ABusiness Summary Oncolytics Biotech Inc., a development stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancers. The company develops REOL
Industry N/AFull Time Employees:N/ABusiness Summary Oncolytics Biotech Inc., a development stage biophar
Offical website >
 
ONCY Address
ONCY
 1167 Kensington Crescent NW
Suite 210
Calgary, AB T2N 1X7
Canada
Phone: 403-670-7377
Fax: 403-283-0858
 
ONCY Latest News
 
Your Comments and Response on Oncolytics Biotech, Inc.
 
ONCY Business Profile
Oncolytics Biotech Inc. (Oncolytics) is a development-stage company. The Company is focused on its research and development of REOLYSIN, which is its cancer therapeutic. REOLYSIN is developed from the reovirus. This virus has been demonstrated in tumour cells bearing an activated Ras pathway. Oncolytics is directing a clinical trial program with the focus of developing REOLYSIN as a human cancer therapeutic. The clinical program includes clinical trials, which it sponsors directly along with Third Party Clinical Trials. Third Party Clinical Trials are clinical trials that are being sponsored by other institutions. As of December 31, 2011, the United States National Cancer Institute (NCI), the University of Leeds and the Cancer Therapy & Research Center at the University of Texas Health Center in San Antonio (CTRC) were sponsoring part of its clinical trial program. Oncolytics uses contract toll manufacturers to produce REOLYSIN.
 
© 2005-2019 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service